Open Letter to AIM Members, Partners, and Friends
AIM letter to members and partners on the end of the COVID-19 Public Health Emergency.
AIM Testimony Regarding Funding for Section 317 Immunization Programs
AIM provides testimony to the House Appropriations Committee Subcommittee on Labor, Health & Human Services, Education, and Related Agencies regarding funding for Section 317 immunization programs.
AIM Legislative Alert: Final FY 2023 Budget
On December 20, 2022, Congress released a final FY 2023 spending bill that includes a $31 million increase for the CDC’s Section 317 Immunization Program.
AIM Comment: Vaccines Federal Implementation Plan
AIM provided comments on the Vaccines Federal Implementation Plan (VFIP). AIM commented on four key areas using lessons learned during the COVID-19 pandemic.
AIM Public Comment on HEDIS MY 2023 Adult Immunization Status Measure
AIM provided public comment on the Proposed Changes and Proposed Measurement Retirements to the Adult Immunization Status Measure (AIS-E).
AIM and NASN SLV Special Supplement
AIM and the National Association of School Nurses (NASN) are excited to share the NASN School Nurse January 2022 Special Supplement “School-Located Vaccination (SLV) Clinics in the Era of COVID-19.”
Lessons from the First Year of COVID-19 Vaccination, and What’s Next?
AIM Policy Consultant Brent Ewig, AIM Executive Director Claire Hannan, and ASTHO CEO Michael Fraser on COVID-19 vaccination and what lies ahead.
AIM Signed on to Protecting Seniors Through Immunization Act Support Letter
AIM joined with several other immunization stakeholders to urge Congress to include the Protecting Seniors Through Immunization Act in the Build Back Better package.
AIM Letters & Comments
Good afternoon everyone, and thank you for all your support and hard work on behalf of the country. I want to quickly review…
Public Comment: July 22, 2021 ACIP Emergency Meeting
Since the beginning of pandemic, immunization program managers have been working long days, nights, and weekends to address the many challenges of vaccinating the nation. The success and impact of this vaccine campaign are nothing short of miraculous.